These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 25246754)

  • 1. A case of mental retardation with paraphilia treated with depot leuprorelin.
    Park WS; Kim KM; Jung YW; Lim MH
    J Korean Med Sci; 2014 Sep; 29(9):1320-4. PubMed ID: 25246754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Case of Paraphilia with Osteoporosis and Administered with Depot Leuprorelin.
    Kim D; Kim KM; Lim MH
    Medicina (Kaunas); 2019 Oct; 55(10):. PubMed ID: 31635190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Effects of Leuprorelin (Leuprolide Acetate) in Sexual Offenders with Paraphilia.
    Choi JH; Lee JW; Lee JK; Jang S; Yoo M; Lee DB; Hong JW; Noh IS; Lim MH
    J Korean Med Sci; 2018 Sep; 33(37):e231. PubMed ID: 30190656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of paraphilia and sexually aggressive impulsive behavior with the LHRH-agonist leuprolide acetate].
    Briken P; Berner W; Noldus J; Nika E; Michl U
    Nervenarzt; 2000 May; 71(5):380-5. PubMed ID: 10846713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraphilias.
    Konrad N; Welke J; Opitz-Welke A
    Curr Opin Psychiatry; 2015 Nov; 28(6):440-4. PubMed ID: 26382165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review.
    Turner D; Briken P
    J Sex Med; 2018 Jan; 15(1):77-93. PubMed ID: 29289377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric and legal features of 113 men convicted of sexual offenses.
    Dunsieth NW; Nelson EB; Brusman-Lovins LA; Holcomb JL; Beckman D; Welge JA; Roby D; Taylor P; Soutullo CA; McElroy SL
    J Clin Psychiatry; 2004 Mar; 65(3):293-300. PubMed ID: 15096066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of paraphilia with luteinizing hormone-releasing hormone agonists.
    Briken P; Nika E; Berner W
    J Sex Marital Ther; 2001; 27(1):45-55. PubMed ID: 11224953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a long-lasting gonadotrophin hormone-releasing hormone agonist in six cases of severe male paraphilia.
    Thibaut F; Cordier B; Kuhn JM
    Acta Psychiatr Scand; 1993 Jun; 87(6):445-50. PubMed ID: 8356897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of paraphilias.
    Thibaut F
    Isr J Psychiatry Relat Sci; 2012; 49(4):297-305. PubMed ID: 23585467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review.
    Briken P; Hill A; Berner W
    J Clin Psychiatry; 2003 Aug; 64(8):890-7. PubMed ID: 12927003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leuprorelin. A review of its pharmacology and therapeutic use in prostatic cancer, endometriosis and other sex hormone-related disorders.
    Plosker GL; Brogden RN
    Drugs; 1994 Dec; 48(6):930-67. PubMed ID: 7533699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Issues to consider in the assessment and treatment of paraphilic patients.
    Saleh FM
    J Clin Psychiatry; 2005 Jun; 66(6):802-3; author reply 803. PubMed ID: 15960581
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacologic treatment of paraphilias.
    Assumpção AA; Garcia FD; Garcia HD; Bradford JM; Thibaut F
    Psychiatr Clin North Am; 2014 Jun; 37(2):173-81. PubMed ID: 24877704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of paraphilia in young adults with leuprolide acetate: a preliminary case report series.
    Saleh FM; Niel T; Fishman MJ
    J Forensic Sci; 2004 Nov; 49(6):1343-8. PubMed ID: 15568711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depot-leuprolide acetate for treatment of paraphilias: a report of twelve cases.
    Krueger RB; Kaplan MS
    Arch Sex Behav; 2001 Aug; 30(4):409-22. PubMed ID: 11446201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy of paraphilias with luteinizing hormone-releasing hormone agonists.
    Briken P
    Arch Gen Psychiatry; 2002 May; 59(5):469-70; author reply 470. PubMed ID: 11982456
    [No Abstract]   [Full Text] [Related]  

  • 18. Naltrexone in the treatment of adolescent sexual offenders.
    Ryback RS
    J Clin Psychiatry; 2004 Jul; 65(7):982-6. PubMed ID: 15291688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypersexual desire in males: are males with paraphilias different from males with paraphilia-related disorders?
    Kafka MP; Hennen J
    Sex Abuse; 2003 Oct; 15(4):307-21. PubMed ID: 14571536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axis I psychiatric disorders, paraphilic sexual offending and implications for pharmacological treatment.
    Kafka M
    Isr J Psychiatry Relat Sci; 2012; 49(4):255-61. PubMed ID: 23585462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.